乳铁蛋白改善高淀粉饲料诱导大口黑鲈生长抑制的作用

Effects of lactoferrin in reducing growth inhibition in Micropterus salmoides induced by a high starch diet

  • 摘要:
    目的 为评估乳铁蛋白在大口黑鲈健康养殖中的应用潜力。
    方法 设计4组等氮等脂饲料:8%淀粉组(LS)、16%淀粉组(HS)及在HS基础上分别添加400 mg/kg(HSL400)和800 mg/kg(HSL800)乳铁蛋白组,饲养大口黑鲈(6.99±0.05) g 70 d。
    结果 相比于LS组,HS组增重率(WGR)、特定生长率(SGR)和蛋白质效率(PER)显著降低,饵料系数(FCR)显著升高;HSL800组生长性能(WGR、SGR、FCR、PER)优于HS组。同HS组相比,HSL800组血清葡萄糖(GLU)、甘油三酯(TG)、总胆固醇(TC)含量及谷丙转氨酶(ALT)和谷草转氨酶(AST)活性显著降低,肝脏脂肪与糖原沉积、空泡化程度显著降低,丙二醛(MDA)含量降低、sodgsh-px表达上调。相比于HS组,HSL800组中肠绒毛高度与数量显著提高,蛋白酶和脂肪酶活性增强,MDA含量和促炎因子il-1βil-8、tnf-α表达下调,抗炎因子il-10、tgf-β1及紧密连接蛋白claudin-1、occludin-1、zo-1表达上调,血清D-乳酸(D-lac)、二胺氧化酶(DAO)和脂多糖(LPS)含量降低。此外,与HS组相比,HSL800组ACE、Chao1和Shannon指数显著升高,肠道菌群健康指数“(厚壁菌门+拟杆菌门+梭杆菌门)/变形菌门”提高,有益菌(鲸杆菌属、硫杆菌属等)相对丰度增加、潜在致病菌(不动杆菌属、气单胞菌属等)及革兰氏阴性菌比例下降。
    结论 乳铁蛋白可通过改善肝脏和肠道健康,有效改善高淀粉饲料对大口黑鲈生长抑制的影响。本研究可为乳铁蛋白在水产动物健康养殖中的应用提供理论依据与技术参数。

     

    Abstract:
    The tolerance threshold of largemouth bass for starch in diet is below 8%. High-starch diet impairs energy metabolism, redox equilibrium, and immunological homeostasis via the "gut-liver" axis, further limiting the aquaculture of largemouth bass. To evaluate the efficacy of lactoferrin in alleviating the adverse effects of high-starch diet and its application in the healthy cultivation of largemouth bass.
    Method The experiment was designed with four groups of isonitrogenous and isolipidic diets: 8% starch group (LS), 16% starch group (HS), and 400 mg/kg (HSL400) and 800 mg/kg (HSL800) lactoferrin groups based on HS. The largemouth bass (6.99±0.05 g) were fed for 70 days. The results indicated that, in comparison to the LS group, the WGR, SGR, and PER of the HS group were greatly diminished, while the FCR was markedly elevated; the growth performance (WGR, SGR, FCR, PER) of the HSL800 group bettered that of the HS group. Compared to the HS group, the HSL800 group exhibited greatly decreased serum levels of GLU, TG, and TC, as well as reduced ALT and AST activity. Additionally, the HSL800 group displayed a significant reduction in liver lipid accumulation, glycogen deposition, and vacuolization, along with decreased MDA levels and increased expression of sod and gsh-px. Compared with the HS group, the HSL800 group exhibited a significant increase in height and the number of intestinal villi, enhanced activities of protease and lipase, reduced levels of MDA, and decreased expression of pro-inflammatory factors il-1β, il-8, and tnf-α. Moreover, in contrast to the HS group, the expression levels of il-10, tgf-β1, claudin-1, occludin-1, and zo-1 were upregulated, whereas serum levels of D-Lac, DAO, and LPS were decreased in the HSL800 group. Furthermore, dietary lactoferrin increased the richness and evenness of the intestinal microbiota (ACE, Chao1 and Shannon), improved the health index of intestinal microbiota "(Firmicutes+Bacteroidetes+Actinobacteria)/Proteobacteria", increased the abundance of beneficial bacteria (Cetobacterium, Thiobacillus and others), and decreased the abundance of some potential harmful bacteria (Acinetobacter, Aeromonas and others) and Gram-negative bacteria. In conclusion, dietary lactoferrin can effectively alleviate the growth inhibition of largemouth bass caused by high-starch feed by improving liver and intestinal health. This study offers a theoretical foundation and technological specifications for the utilization of lactoferrin in the healthful aquaculture of aquatic organisms.

     

/

返回文章
返回